Sign In
Buy NVO
$47.42
+1.52 (+3.31%)
At Close: Jun 23, 2026
Novo Nordisk A/S $NVO Shares Sold by Allspring Global Investments Holdings LLC
03:25am, Thursday, 09'th Apr 2026
Allspring Global Investments Holdings LLC trimmed its holdings in shares of Novo Nordisk A/S (NYSE: NVO) by 64.7% in the undefined quarter, according to the company in its most recent 13F filing with
Novo Nordisk (NVO) Increases Yet Falls Behind Market: What Investors Need to Know
06:46pm, Wednesday, 08'th Apr 2026
In the most recent trading session, Novo Nordisk (NVO) closed at $37.61, indicating a +1.9% shift from the previous trading day.
Which of These Healthcare Stocks Is More Likely to Be a Millionaire Maker?
02:15pm, Wednesday, 08'th Apr 2026
These two companies operate in a high-growth market, one that's heading toward $100 billion, according to analysts' forecasts. Their products have brought in blockbuster revenue.
3 Absurdly Cheap Dividend Stocks to Buy in April 2026
10:00am, Wednesday, 08'th Apr 2026
AbbVie, Novo Nordisk, and Verizon Communications are stellar dividend stocks with strong financials. These stocks pay between 3.4% and 5.8% in dividends.
Why Novo Nordisk's Weight Loss Pill Has Taken Off
02:15pm, Tuesday, 07'th Apr 2026
Novo Nordisk's weight loss pill is expanding the obesity treatment market as an alternative to injectable GLP-1 medications. CNBC spoke with patients about their experience on the pill and explains ho
Novo Nordisk Unveils $399 Wegovy HD, Undercutting Lilly By About 40%
01:14pm, Tuesday, 07'th Apr 2026
Novo Nordisk (NVO) is leaning more aggressively into pricing and formulation upgrades as it looks to regain momentum in the obesity drug market, introducing a h
Can Wegovy HD 7.2 mg drive Novo Nordisk's obesity drug rebound?
10:39am, Tuesday, 07'th Apr 2026
Novo Nordisk announced on Tuesday that it is making a higher-dose version of its popular weight-loss medication, Wegovy, available across the United States. The new 7.2-milligram dose, branded as We
Stock Market Today (LIVE): ASML Faces Challenges From Congress; Broadcom Soars on Google Deal
09:47am, Tuesday, 07'th Apr 2026
Top insights from the latest market news from Tuesday, April 7, from The Motley Fool analysts on Team Rule Breakers and Team Hidden Gems.
Novo Nordisk Launches Higher-Dose Wegovy Weight-Loss Shot in U.S.
08:15am, Tuesday, 07'th Apr 2026
Wegovy HD—offering the highest weight-loss of any Wegovy injection so far—is now available nationwide, the compay said.
Novo Nordisk launches higher-dose Wegovy in the United States
08:03am, Tuesday, 07'th Apr 2026
Novo Nordisk said on Tuesday that it has made a higher-dose version of its blockbuster weight-loss drug Wegovy available across the United States.
Trump's Iran deadline, the Altman-Musk feud, Novo's Wegovy pill and more in Morning Squawk
07:57am, Tuesday, 07'th Apr 2026
Here are five key things investors need to know to start the trading day.
Novo Nordisk's explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment
07:00am, Tuesday, 07'th Apr 2026
Novo Nordisk's new Wegovy GLP-1 pill appears to be expanding the obesity treatment market, drawing in new patients rather than converting existing ones from injections. CNBC spoke with five U.S. patie
Novo Nordisk A/S – Share repurchase programme
06:46am, Tuesday, 07'th Apr 2026
Bagsværd, Denmark, 7 April 2026 – On 4 February 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Counc
Novo Says Weight-Loss Boom Is Just Beginning
10:21am, Monday, 06'th Apr 2026
Novo Nordisk (NVO) is making a simple point. The weight-loss drug boom is nowhere near peak yet.CEO Mike Doustdar says demand is far bigger than what the indust
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:56am, Monday, 06'th Apr 2026
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
